Mucomyst and Ventolin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mucomyst (acetylcysteine) and Ventolin (albuterol). Common drug interactions include pneumonia among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Mucomyst and Ventolin. It is created by eHealthMe based on reports of 76 people who take the same drugs from the FDA, and is updated regularly.

What is Mucomyst?

Mucomyst has active ingredients of acetylcysteine. eHealthMe is studying from 1,835 Mucomyst users. Check the latest studies of Mucomyst.

What is Ventolin?

Ventolin has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 51,849 Ventolin users. Check the latest studies of Ventolin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

76 people who take Mucomyst and Ventolin together, and have interactions are studied.

Mucomyst and Ventolin drug interactions.

What are the common drug interactions of Mucomyst and Ventolin, by gender? *:

female:

Pneumonia
Abdominal discomfort
Abdominal distension
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Breast pain
Breast swelling
Depression
Emotional distress
Face oedema (swelling of face)

male:

Pneumonia
Dyspnoea (difficult or laboured respiration)
Colitis ulcerative (inflammation of colon with ulcer)
Constipation
Cough
Lower respiratory tract infection
Pleural effusion (water on the lungs)
Pruritus (severe itching of the skin)
Pyrexia (fever)
Renal failure (kidney dysfunction)

What are the common drug interactions of Mucomyst and Ventolin, by age (0-1 to 60+)? *:

0-1:

Otitis media acute (rapid inflammation of the middle ear)
Bronchiolitis (inflammation of the membranes lining the bronchioles in lungs)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cough
Dyspnoea (difficult or laboured respiration)
Livedo reticularis (a lace-like purplish discoloration of the skin)
Muscle spasticity (tight or stiff muscles and an inability to control those muscles)
Normochromic normocytic anaemia (forms of anaemia in which the average size and haemoglobin content of the red blood cells are within normal limits)
Otitis media (inflammation of the middle ear)
Oxygen saturation decreased

2-9:

Abdominal distension
Abdominal pain
Blood sodium decreased
Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
Dizziness
Drug ineffective
Dyspnoea (difficult or laboured respiration)
Hepatic steatosis (fatty liver disease)
Hypertension (high blood pressure)
Painful defaecation

10-19:

Breast pain
Breast swelling
Menorrhagia (an abnormally heavy bleeding and prolonged menstrual period at regular intervals)
Viral pericarditis (inflammation of the pericardium (the fibrous sac surrounding the heart) caused by viral infection)

20-29:

n/a

30-39:

Diarrhoea
Weight decreased
Abdominal pain
Anxiety
Appetite disorder (abnormal eating habits)
Blood potassium decreased
Body temperature increased
Bone density decreased
Burning sensation
Chest pain

40-49:

Septic shock (shock due to blood infection)
Bacterial test positive
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cardiac failure
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Difficulty in walking
Multi-organ failure (multisystem organ failure)
Pain in extremity
Pathogen resistance
Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)

50-59:

Leukopenia (less number of white blood cells in blood)
Pruritus (severe itching of the skin)
Pyrexia (fever)
Respiratory depression (respiration has a rate below 12 breaths)
Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
C-reactive protein increased
Cough
Diarrhoea
Dyspnoea (difficult or laboured respiration)
Hoarseness (changing voice)

60+:

Pneumonia
Dyspnoea (difficult or laboured respiration)
Colitis ulcerative (inflammation of colon with ulcer)
Diarrhoea
Lower respiratory tract infection
Multi-organ failure (multisystem organ failure)
Nausea (feeling of having an urge to vomit)
Vomiting
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Fatigue (feeling of tiredness)

What are the existing conditions these people have? *

High Blood Pressure: 9 people, 11.84%
Constipation: 9 people, 11.84%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 9 people, 11.84%
Pain: 8 people, 10.53%
Oedema (fluid collection in tissue): 7 people, 9.21%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 9.21%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 6 people, 7.89%
Insomnia (sleeplessness): 6 people, 7.89%
Infection: 6 people, 7.89%
Hypotension (abnormally low blood pressure): 6 people, 7.89%

* Approximation only. Some reports may have incomplete information.

Do you take Mucomyst and Ventolin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously